The call will cover an update on Merrimack's recent progress as well as a summary of first quarter 2017 financial results. A press release detailing the information to be discussed on the call will be issued the morning of
A listen-only webcast of the call will be available in the Investors section of Merrimack's website, investors.merrimack.com, and a replay of the call will be archived there for six weeks.
Merrimack is a biopharmaceutical company based in
Any statements in this press release about future expectations, plans and prospects for Merrimack constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, as amended. Actual results may differ materially from those indicated by such forward-looking statements. Merrimack anticipates that subsequent events and developments will cause its views to change. However, while Merrimack may elect to update these forward-looking statements at some point in the future, Merrimack specifically disclaims any obligation to do so.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/merrimack-announces-timing-of-first-quarter-2017-investor-conference-call-300449924.html
News Provided by Acquire Media